Showing results (51-60 of 67) with videos related to
Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|May 15, 2023
SMARCB1 regulates the hypoxic stress response in sickle cell traitMelinda Soeung, Luigi Perelli, Ziheng Chen, et al.Science (New York, N.Y.)|September 16, 2021
Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesisEdoardo Del Poggetto, I-Lin Ho, Chiara Balestrieri, et al.Breast Cancer Research : BCR|May 7, 2026
The ARTEMIS trial identifies immune activation as a key predictor of neoadjuvant chemotherapy response in triple-negative breast cancerSahil Seth, Clinton Yam, Lei Huo, et al.Nature|March 5, 2025
Evolutionary fingerprints of epithelial-to-mesenchymal transitionLuigi Perelli, Li Zhang, Sarah Mangiameli, et al.Cancer Cell|February 13, 2019
p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid TumorsAlessandro Carugo, Rosalba Minelli, Luigi Sapio, et al.Gastroenterology|March 22, 2021
Sequential Administration of XPO1 and ATR Inhibitors Enhances Therapeutic Response in TP53-mutated Colorectal CancerAkira Inoue, Frederick S Robinson, Rosalba Minelli, et al.Nature|March 29, 2019
Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancerWantong Yao, Johnathon L Rose, Wei Wang, et al.Cell Reports|January 10, 2019
Functional Genomics Reveals Synthetic Lethality between Phosphogluconate Dehydrogenase and Oxidative PhosphorylationYuting Sun, Madhavi Bandi, Timothy Lofton, et al.Cancer Research|April 6, 2026
DPY30 is an epigenetic decoupler linking replication stress to immunoediting in pancreatic cancerFrancesca Citron, Luca Cecchetto, Elisabetta Granato, et al.Nature|February 9, 2017
Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancerGiannicola Genovese, Alessandro Carugo, James Tepper, et al.Pageof 7